Innovative organisations, iconic institutions and outstanding individuals all feature amongst the shortlisted finalists for the 2015 Melbourne Awards….including CCSVI Australia (also known as NeuroVascular Research Australia).
Tell one…tell all!!! A great opportunity to spread the word about vascular treatment for MS, and the amazing work being done at The Alfred hospital in Melbourne. Check out the #MelbAwards
“Neurovascular Research Australia was initially formed by a team of patients with multiple sclerosis, with an aim to privately raise funds to support research trials and the patient community.
Despite receiving no government funding, their fundraising allowed them to commission a medical trial of the removal of jugular vein obstructions in people with Multiple Sclerosis (MS) to relieve MS symptoms, which was designed and endorsed by MS Research Australia and The Alfred Hospital.
Participants of the trial show a trend that indicates 80 per cent may be affected by this vascular abnormality. Outside of this trial, 66 per cent of those treated experience symptom relief. Once the trial is completed, they hope the Federal Government will subsidise this treatment under Medicare, and MS will be regarded as a treatable disease rather than a doomed diagnosis.
The trial has attracted global interest, funding and talent to The Alfred Hospital, and placed The Alfred at the forefront of medical research, with world-renowned scientists and medical specialists visiting to collaborate.”